| Disease-Modifying, Neuroprotective Effect of N-Acetyl-l-Leucine in Adult and Pediatric Patients With Niemann-Pick Disease Type C 2025 · Age 4–12 years weighing ≥35 kg or age ≥13 years (4 g/day) · Children aged 4–12 years weighing at least 35 kg and adults/adolescents aged 13 years or older with Niemann-Pick disease type C | 4 g | 453 days | 45 |
| Efficacy and safety of N-acetyl-L-leucine in Niemann-Pick disease type C 2022 · NALL, 4 g/day · Patients with Niemann-Pick disease type C aged 6 years or older, including those aged 6–12 years weighing at least 35 kg and patients aged 13 years or older | 4 g | 43 days | 30 |
| The impact of leucine supplementation on body composition and glucose tolerance following energy restriction: an 8-week RCT in adults at risk of the metabolic syndrome 2024 · Leucine · Adults aged 20–65 with obesity, abdominal obesity and at least one additional metabolic-syndrome criterion | 3 g | 8 weeks | 18 |
| Dileucine ingestion, but not leucine, increases lower body strength and performance following resistance training: A double-blind, randomized, placebo-controlled trial 2024 · LEU group · Healthy resistance-trained males, mean age 26.0 ± 6.3 years | 2 g | 10 weeks | 11 |
| Effect of beta-hydroxy beta-methylbutyrate on the onset of blood lactate accumulation and V(O)(2) peak in endurance-trained cyclists 2001 · LEU · Endurance-trained cyclists; age and sex not reported | 3 g | 2 weeks | 8 |
| Disease-Modifying, Neuroprotective Effect of N-Acetyl-l-Leucine in Adult and Pediatric Patients With Niemann-Pick Disease Type C 2025 · Age 4–12 years, 15–<25 kg (2 g/day) · Children aged 4–12 years weighing 15–<25 kg with Niemann-Pick disease type C | 2 g | 453 days | 5 |
| Disease-Modifying, Neuroprotective Effect of N-Acetyl-l-Leucine in Adult and Pediatric Patients With Niemann-Pick Disease Type C 2025 · Age 4–12 years, 25–<35 kg (3 g/day) · Children aged 4–12 years weighing 25–<35 kg with Niemann-Pick disease type C | 3 g | 453 days | 3 |
| Efficacy and safety of N-acetyl-L-leucine in Niemann-Pick disease type C 2022 · NALL, 3 g/day · Patients aged 6–12 years with Niemann-Pick disease type C, weighing 25 to under 35 kg; age range 6–12 years | 3 g | 43 days | 2 |
| Efficacy and safety of N-acetyl-L-leucine in Niemann-Pick disease type C 2022 · NALL, 2 g/day · Patients aged 6–12 years with Niemann-Pick disease type C, weighing 15 to under 25 kg; age range 6–12 years | 2 g | 43 days | 1 |
| Randomized Controlled Trial of a Leucine-Metformin-Sildenafil Combination (NS-0200) on Weight and Metabolic Parameters 2019 · low dose · Adults with obesity | 2.2 g | 16 weeks | — |
| Randomized Controlled Trial of a Leucine-Metformin-Sildenafil Combination (NS-0200) on Weight and Metabolic Parameters 2019 · high dose · Adults with obesity | 2.2 g | 16 weeks | — |
| Leucine and Sildenafil Combination Therapy Reduces Body Weight and Metformin Enhances the Effect at Low Dose: A Randomized Controlled Trial 2021 · Leu/Sil 1.0 · Adults aged 18–65 with obesity (BMI 30–45 kg/m²) | 2.2 g | 24 weeks | — |
| Leucine and Sildenafil Combination Therapy Reduces Body Weight and Metformin Enhances the Effect at Low Dose: A Randomized Controlled Trial 2021 · Leu/Sil 4.0 · Adults aged 18–65 with obesity (BMI 30–45 kg/m²) | 2.2 g | 24 weeks | — |
| Leucine and Sildenafil Combination Therapy Reduces Body Weight and Metformin Enhances the Effect at Low Dose: A Randomized Controlled Trial 2021 · Leu/Met/Sil 1.0 · Adults aged 18–65 with obesity (BMI 30–45 kg/m²) | 2.2 g | 24 weeks | — |
| Leucine and Sildenafil Combination Therapy Reduces Body Weight and Metformin Enhances the Effect at Low Dose: A Randomized Controlled Trial 2021 · Leu/Met/Sil 4.0 · Adults aged 18–65 with obesity (BMI 30–45 kg/m²) | 2.2 g | 24 weeks | — |
| Effect of perindopril or leucine on physical performance in older people with sarcopenia: the LACE randomized controlled trial 2022 · Leucine · Adults aged 70 years and over with sarcopenia | 7.5 g | 1 year | 72 |
| Leucine Supplementation Has No Further Effect on Training-induced Muscle Adaptations 2020 · LEU · Healthy, resistance-trained young men (mean age 27 years) | 10 g | 12 weeks | 12 |
| Randomized pilot study: effects of an exercise programme and leucine supplementation in patients with cirrhosis 2014 · control group · Outpatients with cirrhosis; age and sex not stated | 10 g | 12 weeks | 9 |
| Randomized pilot study: effects of an exercise programme and leucine supplementation in patients with cirrhosis 2014 · exercise group · Outpatients with cirrhosis; age and sex not stated | 10 g | 12 weeks | 8 |
| Effects of free leucine supplementation and resistance training on muscle strength and functional status in older adults: a randomized controlled trial 2015 · Leucine group (LG) · Adults over 70 years of age; men and women; no specific diagnosed condition stated | 10 g | 12 weeks | — |
| Effects of Leucine Administration in Sarcopenia: A Randomized and Placebo-controlled Clinical Trial 2020 · leucine group · Men and women aged 65 years or older living in nursing homes, with sarcopenia | 6 g | 13 weeks | — |
| Efficacy of L-Leucine Supplementation Coupled with a Calorie-Restricted Diet to Promote Weight Loss in Mid-Life Women 2021 · LEU group · Mid-life overweight or obese women following a calorie-restricted diet | 10 g | 12 weeks | — |
| Does supplementation with leucine-enriched protein alone and in combination with fish-oil-derived n-3 PUFA affect muscle mass, strength, physical performance, and muscle protein synthesis in well-nourished older adults? A randomized, double-blind, placebo-controlled trial 2021 · LEU-PRO · Men and women aged 65 years or older at increased risk of sarcopenia | 6.2 g | 24 weeks | 38 |
| Interindividual variability in response to protein and fish oil supplementation in older adults: a randomized controlled trial 2022 · LEU-PRO · Adults aged 65 years or older at risk of sarcopenia; men and women | 6.2 g | 24 weeks | 28 |
| Effects of Whey, Soy or Leucine Supplementation with 12 Weeks of Resistance Training on Strength, Body Composition, and Skeletal Muscle and Adipose Tissue Histological Attributes in College-Aged Males 2017 · LEU · Healthy, untrained college-aged males aged 19–23 | 6 g | 12 weeks | 14 |
| Which of the branched-chain amino acids increases cerebral blood flow in hepatic encephalopathy? A double-blind randomized trial 2018 · leucine group · Adults over 18 with cirrhosis and persistent hepatic encephalopathy | 30 g | 1 year | 11 |
| Effects of a leucine and pyridoxine-containing nutraceutical on fat oxidation, and oxidative and inflammatory stress in overweight and obese subjects 2012 · NuFit active blend · Overweight or obese men and women aged 29 ± 4.5 years | 2.25 g | 4 weeks | 10 |
| The Effect of the Oral Administration of Leucine on Endothelial Function, Glucose and Insulin Concentrations in Healthy Subjects 2019 · Leucine visit · Healthy male volunteers; age not reported | 25 g | 1 day | 10 |
| Unraveling the transcriptomic effects of leucine supplementation on muscle growth and performance in basketball athletes 2025 · leucine supplementation group · Male basketball players aged 18–23 years, university team athletes | 50 mg/kg | 4 weeks | 10 |
| Effects of dietary leucine supplementation on exercise performance 2006 · L-leucine group · Competitive adult outrigger canoeists, women and men, aged 31.6 years on average | 45 mg/kg | 6 weeks | 6 |
| Medium-Chain Triglycerides in Combination with Leucine and Vitamin D Increase Muscle Strength and Function in Frail Elderly Adults in a Randomized Controlled Trial 2016 · LD + MCT · Frail elderly nursing home residents; mean age 86.6 years; 11 men and 27 women enrolled across the study | 1.2 g | 90 days | — |
| Medium-Chain Triglycerides in Combination with Leucine and Vitamin D Increase Muscle Strength and Function in Frail Elderly Adults in a Randomized Controlled Trial 2016 · LD + LCT · Frail elderly nursing home residents; mean age 86.6 years; 11 men and 27 women enrolled across the study | 1.2 g | 90 days | — |
| Medium-Chain Triglycerides in Combination with Leucine and Vitamin D Benefit Cognition in Frail Elderly Adults: A Randomized Controlled Trial 2017 · LD+MCT · Frail elderly nursing-home residents; mean age 86.6 years; sex not stated | 1.2 g | 90 days | — |
| Medium-Chain Triglycerides in Combination with Leucine and Vitamin D Benefit Cognition in Frail Elderly Adults: A Randomized Controlled Trial 2017 · LD+LCT · Frail elderly nursing-home residents; mean age 86.6 years; sex not stated | 1.2 g | 90 days | — |
| Efficacy of leucine-rich high protein supplementation on body composition and muscle function among older adults with sarcopenia: a randomized controlled trial 2026 · Intervention group (Resurge Gold 55+) · Malaysian community-dwelling adults aged 60–90 with low skeletal muscle index and sarcopenia, severe sarcopenia, or pre-sarcopenia; predominantly women | 6 g | 12 weeks | 25 |
| Improving rehabilitation in sarcopenia: a randomized-controlled trial utilizing a muscle-targeted food for special medical purposes 2020 · Experimental formula · Adults aged 65 years or older with sarcopenia admitted for inpatient rehabilitation | 5.6 g | 8 weeks | 70 |
| Tryptophan, glutamine, leucine, and micronutrient supplementation improves environmental enteropathy in Zambian adults: a randomized controlled trial 2019 · Amino acid (AA) supplement · Adults aged 18–60 with environmental enteropathy in Misisi, Lusaka; male and female | 2.79 g | 16 weeks | 42 |
| Does supplementation with leucine-enriched protein alone and in combination with fish-oil-derived n-3 PUFA affect muscle mass, strength, physical performance, and muscle protein synthesis in well-nourished older adults? A randomized, double-blind, placebo-controlled trial 2021 · LEU-PRO plus LC n−3 PUFAs · Men and women aged 65 years or older at increased risk of sarcopenia | 6.2 g | 24 weeks | 38 |
| Anti-sarcopenic effect of leucine-enriched branched-chain amino acid supplementation among elderly chronic kidney disease patients: a double-blinded randomized controlled trial 2025 · oral mixed BCAA supplementation · Patients with chronic kidney disease aged over 65 years | 4.5 g | 12 weeks | 29 |
| Equivalent Hypertrophy and Strength Gains in β-Hydroxy-β-Methylbutyrate- or Leucine-supplemented Men 2019 · whey+leu · Recreationally trained, healthy men; age range not reported | 3 g | 12 weeks | 13 |
| The influence of 8 weeks of whey-protein and leucine supplementation on physical and cognitive performance 2010 · WPL · moderately fit participants; age and sex not stated | 6.2 g | 8 weeks | — |
| Leucine co-ingestion improves post-prandial muscle protein accretion in elderly men 2013 · PRO+LEU · Elderly men, mean age 74.3 years | 2.5 g | 1 day | — |
| Effectiveness of a Novel Food Composed of Leucine, Omega-3 Fatty Acids and Probiotic Lactobacillus paracasei PS23 for the Treatment of Sarcopenia in Elderly Subjects: A 2-Month Randomized Double-Blind Placebo-Controlled Trial 2022 · intervention group (OLEP) · men and women aged 55 years or older with sarcopenia | 2.5 g | 60 days | — |
| Effect of Mixed Meal and Leucine Intake on Plasma Amino Acid Concentrations in Young Men 2018 · LEU · Healthy young men, age 25 ± 1 years | 2 g | 1 day | 10 |
| Effect of Mixed Meal and Leucine Intake on Plasma Amino Acid Concentrations in Young Men 2018 · MEAL-LEU · Healthy young men, age 25 ± 1 years | 2 g | 1 day | 10 |
| Effect of Mixed Meal and Leucine Intake on Plasma Amino Acid Concentrations in Young Men 2018 · MEAL-LEU180 · Healthy young men, age 25 ± 1 years | 2 g | 1 day | 10 |
| Leucine-Enriched Protein Supplementation Increases Lean Body Mass in Healthy Korean Adults Aged 50 Years and Older: A Randomized, Double-Blind, Placebo-Controlled Trial 2020 · protein mixture powder (intervention group) · Healthy Korean adults aged 50–80 years, men and women, without sarcopenia | 6 g | 12 weeks | 54 |
| Interindividual variability in response to protein and fish oil supplementation in older adults: a randomized controlled trial 2022 · LEU-PRO + n-3 · Adults aged 65 years or older at risk of sarcopenia; men and women | 6.2 g | 24 weeks | 30 |
| The Effects of Timing of a Leucine-Enriched Amino Acid Supplement on Body Composition and Physical Function in Stroke Patients: A Randomized Controlled Trial 2020 · breakfast group · Adults aged 40 years and older admitted for rehabilitation after cerebral infarction, cerebral hemorrhage, or subarachnoid hemorrhage | 1.6 g | 60 days | 23 |
| The Effects of Timing of a Leucine-Enriched Amino Acid Supplement on Body Composition and Physical Function in Stroke Patients: A Randomized Controlled Trial 2020 · post-exercise group · Adults aged 40 years and older admitted for rehabilitation after cerebral infarction, cerebral hemorrhage, or subarachnoid hemorrhage | 1.6 g | 60 days | 23 |
| A randomized controlled pilot trial to assess the effectiveness of a specially formulated food supplement and pelvic floor muscle training in women with stress-predominant urinary incontinence 2023 · treatment group · Women with stress or stress-predominant urinary incontinence; ages 53 ± 10 years in this arm | 500 mg | 6 weeks | 18 |
| Post-exercise branched chain amino acid supplementation does not affect recovery markers following three consecutive high intensity resistance training bouts compared to carbohydrate supplementation 2016 · BCAA-CHO · Resistance-trained, apparently healthy males; mean age 21.8 years | 3 g | 4 days | 15 |
| The Effect of a Multi-ingredient Supplement on Resistance Training-induced Adaptations 2021 · SUPP group · Healthy young adults, male and female, mean age 22 ± 2 years, undertaking resistance exercise training | 4 g | 10 weeks | 13 |
| Muscle protein synthesis in cancer patients can be stimulated with a specially formulated medical food 2011 · experimental medical food (EXP) · Adults aged 40 years or older with radiographic evidence of advanced cancer | 8.32 g | 1 day | 12 |
| Acute oral administration of a tyrosine and phenylalanine-free amino acid mixture reduces exercise capacity in the heat 2013 · TYR-free · Healthy, moderately trained men unacclimated to exercise in the heat | 22.5 g | 1 day | 8 |
| Acute oral administration of a tyrosine and phenylalanine-free amino acid mixture reduces exercise capacity in the heat 2013 · BAL · Healthy, moderately trained men unacclimated to exercise in the heat | 22.5 g | 1 day | 8 |
| Randomised clinical trial: a leucine-metformin-sildenafil combination (NS-0200) vs placebo in patients with non-alcoholic fatty liver disease 2018 · NS-0200 treatment B (low dose) · Adults aged 18–75 with NAFLD, MRI-PDFF ≥15%, elevated ALT and BMI 25–40 | 2.2 g | 16 weeks | 35 |
| Randomised clinical trial: a leucine-metformin-sildenafil combination (NS-0200) vs placebo in patients with non-alcoholic fatty liver disease 2018 · NS-0200 treatment C (high dose) · Adults aged 18–75 with NAFLD, MRI-PDFF ≥15%, elevated ALT and BMI 25–40 | 2.2 g | 16 weeks | 32 |
| Effects of L-Leucine Supplementation and Resistance Training on Adipokine Markers in Untrained Perimenopausal and Postmenopausal Women 2024 · leucine (LEU) · Untrained perimenopausal and postmenopausal women | 5 g | 10 weeks | 17 |
| l-Leucine Increases Skeletal Muscle IGF-1 but Does Not Differentially Increase Akt/mTORC1 Signaling and Serum IGF-1 Compared to Ursolic Acid in Response to Resistance Exercise in Resistance-Trained Men 2016 · l-leucine (LEU) · Nine resistance-trained men; age and health condition not stated | 3 g | 1 day | 9 |
| Leucine supplementation attenuates macrophage foam-cell formation: Studies in humans, mice, and cultured macrophages 2018 · Leucine supplementation · Healthy adults | 5 g | 3 weeks | — |
| Leucine-enriched whey protein supplementation, resistance-based exercise, and cardiometabolic health in older adults: a randomized controlled trial 2021 · Protein (P) · Men and women aged 60–90 years, community-dwelling older adults | 90 mg/kg | 16 weeks | 23 |
| Leucine-enriched whey protein supplementation, resistance-based exercise, and cardiometabolic health in older adults: a randomized controlled trial 2021 · Exercise + Protein (EP) · Men and women aged 60–90 years, community-dwelling older adults | 90 mg/kg | 16 weeks | 22 |
| IPP-rich milk protein hydrolysate lowers blood pressure in subjects with stage 1 hypertension, a randomized controlled trial 2010 · MPH2 · Caucasian men and women with stage 1 hypertension or prehypertension; mean age 58 ± 8 years | 4.6 mg | 4 weeks | 70 |
| Enriching a protein drink with leucine augments muscle protein synthesis after resistance exercise in young and older men 2017 · SFO + LEU · Young men aged 24 ± 6 years and older men aged 70 ± 5 years | 4.2 g | 1 day | 18 |
| Leucine coingestion augments the muscle protein synthetic response to the ingestion of 15 g of protein following resistance exercise in older men 2019 · 15G+LEU · Healthy older men, mean age 67 years | 1.5 g | 1 day | 12 |
| Protein leucine content is a determinant of shorter- and longer-term muscle protein synthetic responses at rest and following resistance exercise in healthy older women: a randomized, controlled trial 2018 · CON · Healthy women aged 65–75 years | 2.6 g | — | 11 |
| Leucine Supplementation Does Not Alter Insulin Sensitivity in Prefrail and Frail Older Women following a Resistance Training Protocol 2019 · L-leucine supplementation · Nondiabetic prefrail or frail older women; mean age 77.5 years | 7.5 g | 90 days | — |
| A Randomized Controlled Trial on the Effects of Leucine-Supplement Combined with Nutritional Counseling on Body Composition in Mix Cancer Older Men 2024 · Leucine group · Men aged 60 years or older with gastrointestinal tract or accessory-organ cancer | 7.2 g | 8 weeks | — |
| Leucine supplementation and serum amino acids, testosterone, cortisol and growth hormone in male power athletes during training 1997 · leucine · Adult male track and field power athletes during training | 50 mg/kg | 10 weeks | — |
| Leucine supplementation enhances integrative myofibrillar protein synthesis in free-living older men consuming lower- and higher-protein diets: a parallel-group crossover study 2016 · Leu supplement treatment · Healthy older men aged 65–85 years, consuming lower- or higher-protein diets | 15 g | 3 days | 20 |
| Myofibrillar and Mitochondrial Protein Synthesis Rates Do Not Differ in Young Men Following the Ingestion of Carbohydrate with Whey, Soy, or Leucine-Enriched Soy Protein after Concurrent Resistance- and Endurance-Type Exercise 2019 · SOY + LEU · Healthy recreationally active men aged 20–30 years | 1.14 g | 1 day | 12 |
| Protein Ingestion Induces Muscle Insulin Resistance Independent of Leucine-Mediated mTOR Activation 2015 · Leucine · Obese, sedentary postmenopausal women aged 50–65 years without chronic illness | 68.4 mg/kg | 1 day | 11 |
| Protein leucine content is a determinant of shorter- and longer-term muscle protein synthetic responses at rest and following resistance exercise in healthy older women: a randomized, controlled trial 2018 · LEU · Healthy women aged 65–75 years | 8.4 g | — | 11 |
| Leucine, Not Total Protein, Content of a Supplement Is the Primary Determinant of Muscle Protein Anabolic Responses in Healthy Older Women 2018 · LEU · Healthy older women, mean age 69 years | 6 g | 6 days | 11 |
| Daily requirement for and splanchnic uptake of leucine in healthy adult Indians 2001 · 14 mg leucine × kg⁻¹ × d⁻¹ intake · Healthy adult Indian men | 14 mg | 6 days | 10 |
| Daily requirement for and splanchnic uptake of leucine in healthy adult Indians 2001 · 22 mg leucine × kg⁻¹ × d⁻¹ intake · Healthy adult Indian men | 22 mg | 6 days | 10 |
| Daily requirement for and splanchnic uptake of leucine in healthy adult Indians 2001 · 30 mg leucine × kg⁻¹ × d⁻¹ intake · Healthy adult Indian men | 30 mg | 6 days | 10 |
| Daily requirement for and splanchnic uptake of leucine in healthy adult Indians 2001 · 40 mg leucine × kg⁻¹ × d⁻¹ intake · Healthy adult Indian men | 40 mg | 6 days | 10 |
| Leucine requirement and splanchnic uptake of leucine in chronically undernourished adult Indian subjects 2003 · L-amino acid diet, 14 mg leucine/kg/day · Chronically undernourished adult Indian men | 14 mg | 7 days | 10 |
| Leucine requirement and splanchnic uptake of leucine in chronically undernourished adult Indian subjects 2003 · L-amino acid diet, 30 mg leucine/kg/day · Chronically undernourished adult Indian men | 30 mg | 7 days | 10 |
| Leucine requirement and splanchnic uptake of leucine in chronically undernourished adult Indian subjects 2003 · L-amino acid diet, 22 mg leucine/kg/day · Chronically undernourished adult Indian men | 22 mg | 7 days | 10 |
| Leucine requirement and splanchnic uptake of leucine in chronically undernourished adult Indian subjects 2003 · L-amino acid diet, 40 mg leucine/kg/day · Chronically undernourished adult Indian men | 40 mg | 7 days | 10 |
| Leucine requirement determined in healthy young adult males using the indicator amino acid oxidation method 2024 · 10 mg⋅kg -1 ⋅d -1 leucine intake · Healthy young adult males (mean age 26.9 years) | 10 mg/kg | 1 day | 10 |
| Leucine requirement determined in healthy young adult males using the indicator amino acid oxidation method 2024 · 20 mg⋅kg -1 ⋅d -1 leucine intake · Healthy young adult males (mean age 26.9 years) | 20 mg/kg | 1 day | 10 |
| Leucine requirement determined in healthy young adult males using the indicator amino acid oxidation method 2024 · 30 mg⋅kg -1 ⋅d -1 leucine intake · Healthy young adult males (mean age 26.9 years) | 30 mg/kg | 1 day | 10 |
| Leucine requirement determined in healthy young adult males using the indicator amino acid oxidation method 2024 · 40 mg⋅kg -1 ⋅d -1 leucine intake · Healthy young adult males (mean age 26.9 years) | 40 mg/kg | 1 day | 10 |
| Leucine requirement determined in healthy young adult males using the indicator amino acid oxidation method 2024 · 50 mg⋅kg -1 ⋅d -1 leucine intake · Healthy young adult males (mean age 26.9 years) | 50 mg/kg | 1 day | 10 |
| Leucine requirement determined in healthy young adult males using the indicator amino acid oxidation method 2024 · 65 mg⋅kg -1 ⋅d -1 leucine intake · Healthy young adult males (mean age 26.9 years) | 65 mg/kg | 1 day | 10 |
| Leucine requirement determined in healthy young adult males using the indicator amino acid oxidation method 2024 · 75 mg⋅kg -1 ⋅d -1 leucine intake · Healthy young adult males (mean age 26.9 years) | 75 mg/kg | 1 day | 10 |
| Thirteen weeks of supplementation of vitamin D and leucine-enriched whey protein nutritional supplement attenuates chronic low-grade inflammation in sarcopenic older adults: the PROVIDE study 2019 · active group · Adults aged 65 years or older with mild to moderate physical-function limitations and class I or II sarcopenia | 6 g | 13 weeks | 184 |
| Effects of a nutritional supplement containing Salacia oblonga extract and insulinogenic amino acids on postprandial glycemia, insulinemia, and breath hydrogen responses in healthy adults 2005 · AA · Healthy adults; age and sex not stated | 3.5 g | 1 day | 43 |
| Effects of a nutritional supplement containing Salacia oblonga extract and insulinogenic amino acids on postprandial glycemia, insulinemia, and breath hydrogen responses in healthy adults 2005 · SAA · Healthy adults; age and sex not stated | 3.5 g | 1 day | 43 |
| Preexercise aminoacidemia and muscle protein synthesis after resistance exercise 2012 · BOLUS · Resistance-trained males; age not reported | 5 g | 1 day | 12 |
| Hydrolyzed casein and whey protein meals comparably stimulate net whole-body protein synthesis in COPD patients with nutritional depletion without an additional effect of leucine co-ingestion 2014 · hCAS+LEU · Adults aged 43–77 with moderate to severe COPD and nutritional depletion | 1.5 g | 1 day | 12 |
| Hydrolyzed casein and whey protein meals comparably stimulate net whole-body protein synthesis in COPD patients with nutritional depletion without an additional effect of leucine co-ingestion 2014 · hWHEY+LEU · Adults aged 43–77 with moderate to severe COPD and nutritional depletion | 2.1 g | 1 day | 12 |
| Presleep dietary protein-derived amino acids are incorporated in myofibrillar protein during postexercise overnight recovery 2018 · PRO+leu · Healthy young men after evening resistance-type exercise | 2 g | 1 day | 12 |
| Dileucine-supplemented essential amino acids support whole-body anabolism after resistance exercise and serum-stimulated cell-based anabolism 2025 · Collagen protein control (COL) · Healthy recreationally active adults, 27.0 ± 4.7 years old; 8 men and 4 women | 100 mg | 1 day | 12 |
| Leucine, Not Total Protein, Content of a Supplement Is the Primary Determinant of Muscle Protein Anabolic Responses in Healthy Older Women 2018 · WPI · Healthy older women, mean age 69 years | 6 g | 6 days | 11 |
| Postexercise Dietary Leucine Retention for Whole-Body Anabolism Is Greater With Whey Protein Isolate and Fish-Derived Protein Hydrolysate Than Nonessential Amino Acids in Trained Young Men 2025 · blue whiting-derived protein hydrolysate (BWPH) · trained young men, mean age 31 ± 4 years | 19 mg/kg | 1 day | 10 |
| Postexercise Dietary Leucine Retention for Whole-Body Anabolism Is Greater With Whey Protein Isolate and Fish-Derived Protein Hydrolysate Than Nonessential Amino Acids in Trained Young Men 2025 · whey protein isolate (WPI) · trained young men, mean age 31 ± 4 years | 33 mg/kg | 1 day | 10 |
| Attenuation of the protein wasting associated with bed rest by branched-chain amino acids 1999 · BCAA group · Healthy subjects undergoing bed rest | 30 mmol | 6 days | 8 |
| Leucine-enriched amino acid ingestion after resistance exercise prolongs myofibrillar protein synthesis and amino acid transporter expression in older men 2014 · LEU (leucine-enriched) · Older men after resistance exercise | 3.5 g | 1 day | 8 |
| The impact of postexercise essential amino acid ingestion on the ubiquitin proteasome and autophagosomal-lysosomal systems in skeletal muscle of older men 2017 · leucine · Older men (72 ± 2 years) who performed resistance exercise | 3.5 g | 1 day | 8 |
| Leucine-enriched amino acid ingestion after resistance exercise prolongs myofibrillar protein synthesis and amino acid transporter expression in older men 2014 · Control · Older men after resistance exercise | 1.85 g | 1 day | 7 |
| The impact of postexercise essential amino acid ingestion on the ubiquitin proteasome and autophagosomal-lysosomal systems in skeletal muscle of older men 2017 · control · Older men (72 ± 2 years) who performed resistance exercise | 1.8 g | 1 day | 7 |
| Branched-chain amino acid interactions with reference to amino acid requirements in adult men: valine metabolism at different leucine intakes 1991 · 20 mg valine/kg body weight/day with 80 mg leucine/kg/day · Six young adult men | 80 mg | 5 days | 6 |
| Branched-chain amino acid interactions with reference to amino acid requirements in adult men: valine metabolism at different leucine intakes 1991 · 20 mg valine/kg body weight/day with 40 mg leucine/kg/day · Six young adult men | 40 mg | 5 days | 6 |
| Branched-chain amino acid interactions with reference to amino acid requirements in adult men: valine metabolism at different leucine intakes 1991 · 10 mg valine/kg body weight/day with 80 mg leucine/kg/day · Six young adult men | 80 mg | 5 days | 6 |
| Branched-chain amino acid interactions with reference to amino acid requirements in adult men: valine metabolism at different leucine intakes 1991 · 10 mg valine/kg body weight/day with 40 mg leucine/kg/day · Six young adult men | 40 mg | 5 days | 6 |
| Lysine requirements of chronically undernourished adult Indian men, measured by a 24-h indicator amino acid oxidation and balance technique 2003 · 12 mg lysine/kg/day diet period · Chronically undernourished, otherwise clinically healthy adult Indian men | 40 mg/kg | 7 days | — |
| Lysine requirements of chronically undernourished adult Indian men, measured by a 24-h indicator amino acid oxidation and balance technique 2003 · 30 mg lysine/kg/day diet period · Chronically undernourished, otherwise clinically healthy adult Indian men | 40 mg/kg | 7 days | — |
| Lysine requirements of chronically undernourished adult Indian men, measured by a 24-h indicator amino acid oxidation and balance technique 2003 · 18 mg lysine/kg/day diet period · Chronically undernourished, otherwise clinically healthy adult Indian men | 40 mg/kg | 7 days | — |
| Lysine requirements of chronically undernourished adult Indian men, measured by a 24-h indicator amino acid oxidation and balance technique 2003 · 36 mg lysine/kg/day diet period · Chronically undernourished, otherwise clinically healthy adult Indian men | 40 mg/kg | 7 days | — |
| Lysine requirements of chronically undernourished adult Indian men, measured by a 24-h indicator amino acid oxidation and balance technique 2003 · 24 mg lysine/kg/day diet period · Chronically undernourished, otherwise clinically healthy adult Indian men | 40 mg/kg | 7 days | — |
| Lysine requirements of chronically undernourished adult Indian men, measured by a 24-h indicator amino acid oxidation and balance technique 2003 · 42 mg lysine/kg/day diet period · Chronically undernourished, otherwise clinically healthy adult Indian men | 40 mg/kg | 7 days | — |
| The daily valine requirement of healthy adult Indians determined by the 24-h indicator amino acid balance approach 2005 · valine intake 5 mg x kg(-1) x d(-1) · healthy, well-nourished Indian men | 40 mg/kg | 7 days | — |
| The daily valine requirement of healthy adult Indians determined by the 24-h indicator amino acid balance approach 2005 · valine intake 10 mg x kg(-1) x d(-1) · healthy, well-nourished Indian men | 40 mg/kg | 7 days | — |
| The daily valine requirement of healthy adult Indians determined by the 24-h indicator amino acid balance approach 2005 · valine intake 15 mg x kg(-1) x d(-1) · healthy, well-nourished Indian men | 40 mg/kg | 7 days | — |
| The daily valine requirement of healthy adult Indians determined by the 24-h indicator amino acid balance approach 2005 · valine intake 20 mg x kg(-1) x d(-1) · healthy, well-nourished Indian men | 40 mg/kg | 7 days | — |
| The daily valine requirement of healthy adult Indians determined by the 24-h indicator amino acid balance approach 2005 · valine intake 25 mg x kg(-1) x d(-1) · healthy, well-nourished Indian men | 40 mg/kg | 7 days | — |
| The daily valine requirement of healthy adult Indians determined by the 24-h indicator amino acid balance approach 2005 · valine intake 30 mg x kg(-1) x d(-1) · healthy, well-nourished Indian men | 40 mg/kg | 7 days | — |
| The daily valine requirement of healthy adult Indians determined by the 24-h indicator amino acid balance approach 2005 · valine intake 35 mg x kg(-1) x d(-1) · healthy, well-nourished Indian men | 40 mg/kg | 7 days | — |
| Branched-chain amino acid interactions with reference to amino acid requirements in adult men: leucine metabolism at different valine and isoleucine intakes 1991 · Phase 1: leucine 40 mg/kg/day, valine 80 mg/kg/day, isoleucine 62 mg/kg/day · Healthy young adult men; six subjects were in phase 1 | 40 mg | 5 days | — |
| Branched-chain amino acid interactions with reference to amino acid requirements in adult men: leucine metabolism at different valine and isoleucine intakes 1991 · Phase 1: leucine 15 mg/kg/day, valine 80 mg/kg/day, isoleucine 62 mg/kg/day · Healthy young adult men; six subjects were in phase 1 | 15 mg | 5 days | — |
| Branched-chain amino acid interactions with reference to amino acid requirements in adult men: leucine metabolism at different valine and isoleucine intakes 1991 · Phase 1: leucine 15 mg/kg/day, valine 20 mg/kg/day, isoleucine 62 mg/kg/day · Healthy young adult men; six subjects were in phase 1 | 15 mg | 5 days | — |
| Branched-chain amino acid interactions with reference to amino acid requirements in adult men: leucine metabolism at different valine and isoleucine intakes 1991 · Phase 2: leucine 15 mg/kg/day, valine 20 mg/kg/day, isoleucine 62 mg/kg/day · Healthy young adult men; five subjects were in phase 2 | 15 mg | 5 days | — |
| Branched-chain amino acid interactions with reference to amino acid requirements in adult men: leucine metabolism at different valine and isoleucine intakes 1991 · Phase 2: leucine 40 mg/kg/day, valine 20 mg/kg/day, isoleucine 20 mg/kg/day · Healthy young adult men; five subjects were in phase 2 | 40 mg | 5 days | — |
| Branched-chain amino acid interactions with reference to amino acid requirements in adult men: leucine metabolism at different valine and isoleucine intakes 1991 · Phase 2: leucine 15 mg/kg/day, valine 20 mg/kg/day, isoleucine 20 mg/kg/day · Healthy young adult men; five subjects were in phase 2 | 15 mg | 5 days | — |
| Protein Ingestion before Sleep Increases Overnight Muscle Protein Synthesis Rates in Healthy Older Men: A Randomized Controlled Trial 2017 · PRO20+LEU · Healthy older men; mean age 72 years | 1.5 g | 1 day | — |
| Modulation of Energy Sensing by Leucine Synergy with Natural Sirtuin Activators: Effects on Health Span 2020 · leucine-resveratrol · Prediabetic subjects; age and sex not stated | 1.11 g | 4 weeks | — |
| Safety and tolerability of 6-month supplementation with a vitamin D, calcium and leucine-enriched whey protein medical nutrition drink in sarcopenic older adults 2020 · One-serving WP-MND group during the open-label extension · Adults aged 65 years or older with sarcopenia who continued from the RCT | 3 g | 13 weeks | 133 |
| Dileucine-supplemented essential amino acids support whole-body anabolism after resistance exercise and serum-stimulated cell-based anabolism 2025 · Dileucine-containing essential amino acid supplement (DIEAA) · Healthy recreationally active adults, 27.0 ± 4.7 years old; 8 men and 4 women | 1.1 g | 1 day | 12 |
| Dileucine-supplemented essential amino acids support whole-body anabolism after resistance exercise and serum-stimulated cell-based anabolism 2025 · Branched-chain amino acid (BCAA) supplement · Healthy recreationally active adults, 27.0 ± 4.7 years old; 8 men and 4 women | 3.1 g | 1 day | 12 |
| Tryptophan, glutamine, leucine, and micronutrient supplementation improves environmental enteropathy in Zambian adults: a randomized controlled trial 2019 · AA plus MM supplement · Adults aged 18–60 with environmental enteropathy in Misisi, Lusaka; male and female | 2.79 g | 16 weeks | — |